Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin
BMJ GroupEpisode Description
More Episodes
-
0Managing Systemic Lupus Erythematosus: the latest EULAR recommendations
-
0A non-pharma approach in systemic lupus erythematosus and systemic sclerosis
-
0Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases
-
0The EULAR COVID-19 database and its insights into risk factors
-
0Predictors of disease worsening in systemic sclerosis
-
0Treating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumab
-
0The dose dependent effect of statins on osteoporosis
-
0A prediction score for individuals at risk to develop rheumatoid arthritis
-
0Prediction of radiographic progression using synovitis characteristics
-
0Six-week treatment with low-dose prednisolone in patients with painful hand osteoarthritis
-
0Highlights from ACR: guselkumab, ixekizumab and secukinumab in SpA
-
0TULIP 2: Efficacy and Safety of Anifrolumab in Patients
-
0TULIP 1 - highlights from the ACR meeting
-
0Capture Hi-C reveals novel drug targets in rheumatic diseases
-
0EULAR recommendations for the management of systemic lupus erythematosus
-
0Musculoskeletal diseases on the rise worldwide and affecting developed countries the most
-
0Three tips to get your manuscript published by ARD
-
0Early inflammatory arthritis outcomes: what changed in the new millennium?
-
0Similar performance of Humira and BI695501 biosimilar in active rheumatoid arthritis
-
0Patient and doctor discordance may reduce chances of remission in rheumatoid and psoriatic arthritis
-
0Lupus and Hughes syndrome: EULAR recommendations for women’s health and family planning
-
0Inflammatory arthritis and sicca syndrome induced by cancer treatment
-
0Johannes Bijlsma
Comments (0)
0/500
New Comments(0)
What do you think of this episode?